Thus, the TNFSF4/OX40L axis has emerged as a pivotal and tunable therapeutic target spanning a broad spectrum of human diseases, including autoimmune disorders, chronic inflammation, and malignancies. The gene discussed is TNFSF4; the disease is autoimmune disease.